发明名称 |
A NOVEL PHARMACEUTICAL COMPOSITION FOR INHALATION CONTAININGCR 2039 (ANDOLAST) |
摘要 |
A pharmaceutical composition comprising, as active ingredient, N-4-(1H-tetrazol-5-yl)phenyl-4-(1H-tetrazol-5-yl)benzamide disodium salt (CR 2039, Andolast) or another pharmaceutically-acceptable salt thereof and a flavouring, and optionally including a pharmaceutically-acceptable inert carrier and/or a pharmaceutically-acceptable sweetener, the composition being suitable for administration by oral inhalation.
|
申请公布号 |
CA2244357(A1) |
申请公布日期 |
1999.02.08 |
申请号 |
CA19982244357 |
申请日期 |
1998.07.30 |
申请人 |
ROTTA RESEARCH LABORATORIUM S.P.A. |
发明人 |
ROVATI, LUCIO CLAUDIO;SENIN, PAOLO;MAKOVEC, FRANCESCO |
分类号 |
A61K9/72;A61K9/00;A61K9/14;A61K31/41;A61K47/26;A61K47/36;A61K47/44;A61P11/00;A61P11/06;A61P37/08;(IPC1-7):A61K31/41 |
主分类号 |
A61K9/72 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|